Patient Discovery Raises $2M in Series A Funding to Revolutionize Oncology Care and SDoH Integration

Patient Discovery, a pioneering healthcare technology company, is excited to announce that it has successfully raised $2,000,000 in its latest funding round. This significant infusion of capital will be dedicated to advancing the company’s innovative solutions for oncology practices, particularly as they address the critical challenges posed by Social Determinants of Health (SDoH). By integrating a suite of tools that combine patient engagement, revenue cycle management, and comprehensive workflow support, Patient Discovery is uniquely positioned to streamline operations and improve the delivery of care. The fresh funding will accelerate the development of new functionalities that aim to maximize reimbursements and enhance clinical outcomes. This means that oncology practices will not only be better equipped to manage their day-to-day operations but also empowered to improve the overall well-being of their patients by recognizing and addressing the social factors that influence health outcomes. As the healthcare industry continues to evolve, especially under the pressures of unprecedented global challenges, Patient Discovery’s commitment to innovation and excellence remains a driving force behind its mission to transform patient care. With the additional capital, the company is set to expand its research and development efforts, invest in state-of-the-art technology, and broaden its impact across more oncology practices nationwide. This funding round marks a milestone in Patient Discovery’s journey towards becoming a critical partner in healthcare, ensuring that oncology providers have the resources they need to deliver high-quality, patient-centered care while adapting seamlessly to today’s complex clinical and administrative landscapes.